Madrigal Pharmaceuticals, Inc (MDGL) insider trading
Every open-market stock purchase and sale by Madrigal Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $71.7M over the last 12 months (25 sales). No open-market buys.
- Last insider buy: Baker Bros. Advisors LP (Insider), $5.2M, 13 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $71.7M (25 sales). Last close $486.98 on Jun 4, 2026.
Recent MDGL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | Baker Bros. Advisors LP (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Jacqualyn A Fouse (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Rebecca Taub (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Daniel J. Brennan (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Daniel J. Brennan (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Baker Bros. Advisors LP (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Rebecca Taub (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Richard S Levy (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Jacqualyn A Fouse (Director) | Bought (not open market) | — |
| Jun 17, 2026 | James M Daly (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Richard S Levy (Director) | Bought (not open market) | — |
| Jun 17, 2026 | James M Daly (Director) | Bought (not open market) | — |
| Jun 1, 2026 | David Soergel (C-suite exec) | Sold | $517K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $775K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $406K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $374K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $339K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $312K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $225K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $177K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $163K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $77.1K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $41.6K |
| May 22, 2026 | Richard S Levy (Director) | Sold | $20.5K |
| May 18, 2026 | David Soergel (C-suite exec) | Sold | $435K |
Who's trading MDGL
- Jacqualyn A Fouse, Director: other filings, last Jun 17, 2026
- Baker Bros. Advisors LP, Director: other filings, last Jun 17, 2026
- Daniel J. Brennan, Director: other filings, last Jun 17, 2026
- Richard S Levy, Director: sold $7.3M (25 sales), last Jun 17, 2026
- James M Daly, Director: other filings, last Jun 17, 2026
- Rebecca Taub, Director: sold $20.9M (38 sales), last Jun 17, 2026
- David Soergel, C-suite exec: sold $952K (2 sales), last Jun 1, 2026
- Carole Huntsman, C-suite exec: sold $1.4M (9 sales), last Mar 6, 2026
- Mardi Dier, CFO: sold $3M (19 sales), last Mar 6, 2026
- Shannon T Kelley, General Counsel: sold $500K (3 sales), last Mar 6, 2026
- William John Sibold, CEO: sold $2.9M (3 sales), last Mar 6, 2026
- Rita Thakkar, C-suite exec: other filings, last Jan 15, 2026
- Paul A Friedman, Director: sold $26.6M (37 sales), last Jan 9, 2026
- Kenneth Bate, Director: sold $8M (11 sales), last Nov 5, 2025
Get free alerts when an insider at Madrigal Pharmaceuticals, Inc files a new trade →